Abstract:Background: Epstein-Barr virus (EBV) infection is a crucial risk factor for nasopharyngeal carcinoma (NPC), but the mechanism for its elevated activation level in NPC endemic areas remains unclear. This study aims to identify the EBV natural variations contributed to the different reactivation potential between NPC endemic and non-endemic areas. Methods: 1030 subjects were recruited in China, including 303 healthy individuals from two NPC non-endemic areas, 483 healthy people from three endemic areas and 244 NPC patients. Among which, saliva DNA samples from 244 participants were sequenced for the EBV immediate early (IE) genes of BRLF1 and BZLF1, their promoters were included: the rest 786 subjects were used for the validation of significant variations among three different populations. Haplotype and population structure analysis were conducted. Dual-luciferase assay was used to detect the promoter activity. Results: A total of 246 distinct variations were detected, 29 showed significant difference in the frequencies between healthy people from NPC endemic area and non-endemic area. Population structure analysis clustered EBV strains into 9 subgroups mostly in accordance with the geographical origin of samples. Interestingly, two EBV genotypes, Rp-V1 and Rp-V2. were identified according to the linkage relationship of the variations in BRLF1 promoter ( Rp ). Rp-V1 has higher frequency in NPC endemic areas than in non-endemic areas (52.38% vs 18.15%. P = 2.07 x 10(-1)(4)), and was associated with higher oral EBV DNA levels (adjusted OR = 1.64, 95% CI = 1.21-2.24, P = .002), suggesting a more powerful activation ability of Rp-V1 than that of the prototype Rp-of the EBV strain: On the contrary, Rp-V2 has higher frequency in NPC non-endemic areas than in endemic areas (1848% vs 0.38%, P = 1.17 x10(-7)), might represent a reduced activation potential of EBV. Further dual-luciferase assay showed Rp-V1 has higher promoter activity while compared with Rp-V2 (P < .0001). Notably, Rp-V1 impaired the transcription repression effect of YY1 while Rp-V2 strengthened the transcription repression effect of EBF1 on Rp. In addition, significant differences of Rta 393-407 CTL epitope which may influence the recognition of Rta by CD8+T cells were detected between healthy people from NPC endemic area and non-endemic area. Conclusions: This study identified natural variations in cis-acting elements (YY1 and EBF1) of EBV Rp altering Rp transcription activities, which may contribute to the elevated EBV activation level in NPC endemic areas than non-endemic areas. (C) 2018 Published by Elsevier B.V.

Human Genetic Variants of Homologous Recombination Repair Genes First Found to Be Associated with Epstein-Barr Virus Antibody Titers in Healthy Cantonese

Epstein-Barr Virus Variation in People Living with Human Immunodeficiency Virus in Southeastern China.

Association Between HLA Alleles and Epstein-Barr Virus Zta-IgA Serological Status in Healthy Males from Southern China

Abstract #LB-227: Identifying a Subtype of Epstein-Barr Virus As a Valuable Indicator for a High Risk of NPC in Southern China

Host Genetic Variants, Epstein-Barr Virus Subtypes, and the Risk of Nasopharyngeal Carcinoma: Assessment of Interaction and Mediation

A Single Nucleotide Polymorphism in the Epstein-Barr Virus Genome is Strongly Associated with a High Risk of Nasopharyngeal Carcinoma

A comprehensive analysis of genetic diversity of EBV reveals potential high-risk subtypes associated with nasopharyngeal carcinoma in China

Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers.

Meta-analysis of Epstein-Barr virus genomes in Southern Chinese identifies genetic variants and high risk viral lineage associated with nasopharyngeal carcinoma

Association Between Antibodies That Bind Epstein-Barr Virus (EBV) gp350 and gH/gL and Shedding of EBV in Saliva From Nasopharyngeal Carcinoma Multiplex Family Members in Taiwan

High risk Epstein‐Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma

Fluctuations Of Epstein-Barr Virus Serological Antibodies And Risk For Nasopharyngeal Carcinoma: A Prospective Screening Study With A 20-Year Follow-Up

Genome Sequencing Analysis Identifies High-Risk Epstein-Barr Virus Subtypes for Nasopharyngeal Carcinoma

The Character of EBNA1 Gene Variation in Cantonese and Its Association with Nasopharyngeal Carcinoma

Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.

Elevated Epstein-Barr Virus Seroreactivity among Unaffected Members of Families with Nasopharyngeal Carcinoma

Interactions Between DNA-repair Genes and Epstein-Barr Virus Associated with the Susceptibility of Nasopharyngeal Carcinoma: A Primary Study

The Relationship Between Environmental Factors and the Profile of Epstein-Barr Virus Antibodies in the Lytic and Latent Infection Periods in Healthy Populations from Endemic and Non-Endemic Nasopharyngeal Carcinoma Areas in China.

Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults

Environmental Factors for Epstein-Barr Virus Reactivation in a High-Risk Area of Nasopharyngeal Carcinoma: A Population-Based Study

Serologic Markers of Viral Infection and Risk of Non-Hodgkin Lymphoma: A Pooled Study of Three Prospective Cohorts in China and Singapore